MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Apraxia of speech as the initial manifestation of progressive supranuclear palsy

    J.J. Bravo, M.J. Gallardo, J.P. Cabello, R.E. Ibañez, J. Vaamonde (Ciudad Real, Spain)

    Objective: We report a patient with apraxia of speech as the initial symptom who finally developed a progressive supranuclear palsy. Background: Progressive supranuclear palsy (PSP)…
  • 2016 International Congress

    High frequency of mutations in the glucocerebrosidase (GBA) gene among Ashkenazi Jews with dementia with Lewy bodies

    T. Shiner, A. Mirelman, M. Gana Weisz, A. Bar-Shira, E. Ash, R. Cialic, T. Gurevich, N. Bregman, A. Orr-Urtreger, N. Giladi (Tel Aviv, Israel)

    Objective: The objective of this study was to characterize, clinically and genetically, anAshkenazi Jewish cohort of patients diagnosed with DLB, looking for the association with…
  • 2016 International Congress

    Early stridor onset predicts survival in multiple system atrophy

    G. Giannini, G. Calandra-Buonaura, F. Mastrolilli, M. Righini, M.L. Bacchi-Reggiani, P. Guaraldi, F. Provini, P. Cortelli (Bologna, Italy)

    Objective: To evaluate the predictive value of stridor and of its latency of onset in a cohort of Multiple System Atrophy (MSA) patients referred to…
  • 2016 International Congress

    Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy

    Y. Lee, D.K. Lee, J.M. Lee, S.J. Chung, J.J. Lee, Y.H. Sohn, P.H. Lee (Seoul, Korea)

    Objective: We aimed to evaluate cerebellar involvement in PSP using MRI segmental volumetric analysis. Background: Progressive supranuclear palsy (PSP) is characterized clinically as postural instability…
  • 2016 International Congress

    Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature

    C. Wilke, J.K. Pomper, S. Biskup, C. Puskás, D. Berg, M. Synofzik (Tübingen, Germany)

    Objective: To provide a systematic clinical characterisation of C9orf72-associated parkinsonism. Background: While C9orf72 repeat expansions usually present with frontotemporal dementia (FTD) and/or amyotrophic lateral sclerosis…
  • 2016 International Congress

    Transient mild hyperglycemia as diagnostic tool for idiopatic Parkinson’s disease triggered by psychoemotional stress

    M.N. Khanova, K.A. Rasulova (Tashkent, Uzbekistan)

    Objective: We studied clinical features and the levels of glucose in blood of patients with idiopathic PD (IPD) of different sages and duration who had…
  • 2016 International Congress

    Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease

    R. Zangaglia, E. Guaschino, N. Ghiotto, B. Minafra, M. Terzaghi, G. Capone, A. Spiritelli, D. Bosone, C. Pacchetti (Pavia, Italy)

    Objective: Aim of our study is to correlate the autonomic nervous system failure and circadian rhythm of arterial blood pressure in idiopathic REM behaviour disorders…
  • 2016 International Congress

    Influence of onset age on the progression of non-motor symptoms in Parkinson’s disease: A prospective study from Southwest China

    R. Ou, B. Cao, Q. Wei, K. Chen, W. Song, J. Yang, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)

    Objective: To explore the influence of onset age on the progression of non-motor symptoms (NMS) in Parkinson's disease. Background: NMS are gaining increasing relevance in…
  • 2016 International Congress

    Cerebral vasoreactivity in Parkinson’s disease and multiple system atrophy: A pilot study

    E. Indelicato, F.E. Pontieri, D. Benincasa, A. Fanciulli, F. Orzi, M. Giovannelli, G. Sette (Rome, Italy)

    Objective: To compare cerebral vasoreactivity in Parkinson´s disease (PD) and multiple system atrophy (MSA) patients with or without cardiovascular autonomic failure (CAF). Background: CAF is…
  • 2016 International Congress

    Comorbidity and Parkinson’s disease phenotype, dopaminergic function and CSF biomarkers

    T. Yousaf, G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To evaluate the influence of comorbidity on clinical phenotype, dopaminergic function and CSF biomarkers in a population of de novo Parkinson's disease (PD) patients.…
  • « Previous Page
  • 1
  • …
  • 1747
  • 1748
  • 1749
  • 1750
  • 1751
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley